Ethereum trades at $2,396 (€2,137) as of October 19, 2026, down 39.7% in USD and 37.5% in euros since October 2025. The difference is due to the USD strengthening against the euro, affecting tax calculations for German investors who must convert prices using the ECB reference rate. The one-year holding period for tax exemption is critical, with losses in euros potentially differing from USD figures. Investors should track prices and conversions carefully for accurate tax reporting and consider trading directly in euros to avoid currency effects.
Ethereum's price in euros is €2,137 as of October 20, 2026. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Oct 20, 2026 03:42 WIB: out of 50 priced major cryptocurrencies, 46 rose and 3 fell today. Notable movers include SNX at Rp3.868 with a 1-day change of +5.54% and Pluang order activity of 99% Sell / 1% Buy, SUSHI at Rp3.877 with +5.17% change and 55% Sell / 45% Buy order activity, and XTZ at Rp5.408 with +5.17% change and 0% Sell / 100% Buy order activity, with typical hold times ranging from 70 to 102 days.
The Hershey Trust Company sold 1,512 common shares under a trading plan but kept voting control through Class B shares. Hershey will report Q3 earnings on October 29, with investors focused on how price increases affected Halloween-season demand. Q2 ...
W. R. Berkley reported mixed Q3 2026 results with earnings per share of $1.17 beating estimates, but revenue fell short at $3.74 billion versus $3.82 billion expected. The company saw premium growth with gross premiums up 3% and net premiums up 1%, s...
GE Aerospace is set to report its Q3 earnings with analysts forecasting a 21.7% rise in earnings per share to $2.02 and nearly 12% revenue growth to about $12.7 billion. Despite consistently beating estimates, the stock has fallen after past reports ...
Silence Therapeutics' stock surged 125.6% to $19.58 following Merck KGaA's agreement to acquire the RNA-interference drug developer for about $1.3 billion in equity value. Merck will pay $20 per share, a 130% premium over the recent closing price. Ot...
On October 19, 2026, several stocks saw significant declines. Iambic Therapeutics dropped 31.4% but stayed just above its IPO price of $16 after raising $150 million. TCGX Acquisition fell 18.5% following its announcement of a merger with TriGemX Bio...
